Using in vitro melanoma cell line-based screening, we previously identified an inhibitor of SIRT2, AC-93253, as a compound that downregulates the expression of genes involved in melanoma progression and chemoresistance acquisition [49]. The gene discussed is SIRT2; the disease is melanoma.